Author | Jason Harris | OncLive

Author | Jason Harris


OncLive® Honors 15 Cancer Care Pioneers

October 06, 2020

The 2020 class of Giants of Cancer Care® award winners hail from around the globe, coming from locales such as Lagos, Nigeria; Amsterdam, the Netherlands; Brussels, Belgium; and Philadelphia, Pennsylvania.

Regorafenib Showed Modest Activity in Ewing Sarcoma

September 20, 2020

Regorafenib extended progression-free survival at 24 weeks compared with placebo for patients with Ewing sarcoma in the phase 2 REGOBONE study. However, the oral multi-kinase inhibitor failed to meet the study’s primary endpoint of non-progression at 8 weeks.